BIZTRAC BETA
Manufacture of pharmaceutical preparations

ALGINOR PHARMA INGREDIENTS AS

Org. no. 928521672 Limited company (AS) Karmøy Incorporated 2021 Active
Ownership graph ↗
Operating profit NOK −317,000
Equity NOK 9.8m
Incorporated 2021
Share capital NOK 10.0m

Signals

2 flags
  • Driftsunderskudd 2024 Siste driftsresultat er negativt (−317k kr).
  • Nylig endring 2026-04-25 Adresseendring registrert 2026-04-25.

ALGINOR PHARMA INGREDIENTS AS is registered as a limited company in Karmøy, Rogaland with organisation number 928521672. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2021. Registered share capital is NOK 10.0m, divided into 100000 shares. The company's stated purpose is: “Bedriftsrådgivning, forretningsutvikling, investering, forskning og utvikling, innovasjon, produksjon, handel og distribusjon.”.

Key figures · 2024

Operating profit
NOK −317,000
Equity
NOK 9.8m
Est. value
NOK 11.5m

Financial health · 2024

Liquidity
0.27
Not satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
29.6%
Good
Equity as a share of total capital

Who owns ALGINOR PHARMA INGREDIENTS AS?

ALGINOR ASA
ALGINOR PHARMA INGREDIENTS AS
· NOK −317,000 profit

ALGINOR PHARMA INGREDIENTS AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about ALGINOR PHARMA INGREDIENTS AS

Who owns ALGINOR PHARMA INGREDIENTS AS?

ALGINOR ASA is the largest registered owner, with 100.0%.

Who is the general manager of ALGINOR PHARMA INGREDIENTS AS?

Steen Mylius Stricker Lund is registered as general manager of ALGINOR PHARMA INGREDIENTS AS.

Where is ALGINOR PHARMA INGREDIENTS AS based?

ALGINOR PHARMA INGREDIENTS AS has its business address in Avaldsnes.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.